(Q39469522)

12 September 2017

1 reference

title

An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride). (English)

1 reference

12 September 2017

Smith GW

1

1 reference

12 September 2017

O'Connor SE

series ordinal

2

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

American Journal of Cardiology

12 September 2017

published in

1 reference

12 September 2017

volume

62

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

9C-17C

1 reference

A new inotropic drug: its promise and a caution

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

A Comparison of the Vascular Dopamine Receptor with Other Dopamine Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Letter: Salbutamol: agonistic and antagonistic activity at beta--adrenoceptor sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Non-catechol phenylethanolamines: agonistic and antagonistic actions on beta-adrenoreceptors in isolated tissues from the guinea-pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Cardiovascular ?-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Inhibition of Uptake1 by dopexamine hydrochloride in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Indirect sympathomimetic actions of dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

The effects of dopexamine on the cardiovascular system of the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

In vivo analysis of adrenergic receptor activity of dobutamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Alterations of cardiac sympathetic neurotransmitter activity in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

Plasma norepinephrine in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980061-4

10.1016/S0002-9149(88)80061-4

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference